Advancements in the clinical biometrics space – from trial design to visualization and analytics, have the potential to dramatically improve efficiency and success in drug development. At the same time, industry professionals face an array of challenges from regulatory pressures to skills shortages. Cytel, a leading biometrics CRO and clinical trial software provider is conducting a brief survey to assess what industry professionals agree are the key challenges to overcome, and the most promising developments in the clinical biometrics space today. We will share high level data from the survey by the end of 2017, followed by more in depth insights and commentary.
The survey should take no more than 3- 4 minutes to complete an average of 7 questions. For each completed survey we will make a donation to the Conquer Cancer Foundation.
